Tonix Pharma's total assets for Q3 2024 were $94.99M, an increase of 35.11% from the previous quarter. TNXP total liabilities were $20.78M for the fiscal quarter, a -26.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.